Primary Graft Dysfunction in Heart Transplant Recipients-Risk Factors and Longitudinal Outcomes
| Autor: | Gavin Hickey, Michael V. Genuardi, Robert L. Kormos, Arman Kilic, Sina Salehi Omran, Edward T. Horn, Mary E. Keebler, Christopher M. Sciortino, Nicholas F. Smith |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Inotrope
Adult medicine.medical_specialty medicine.medical_treatment Biomedical Engineering Biophysics Primary Graft Dysfunction Bioengineering Amiodarone Logistic regression Biomaterials Risk Factors Internal medicine medicine Lung transplantation Humans Retrospective Studies business.industry Incidence (epidemiology) General Medicine Perioperative respiratory system Transplant Recipients Heart Transplantation lipids (amino acids peptides and proteins) business Body mass index medicine.drug Lung Transplantation |
| Zdroj: | ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(3) |
| ISSN: | 1538-943X |
| Popis: | Before the 33rd Annual International Society for Heart and Lung Transplantation conference, there was significant intercenter variability in definitions of primary graft dysfunction (PGD). The incidence, risk factors, and outcomes of consensus-defined PGD warrant further investigation. We retrospectively examined 448 adult cardiac transplant recipients at our institution from 2005 to 2017. Patient and procedural characteristics were compared between PGD cases and controls. Multivariable logistic regression was used to model PGD and immediate postoperative high-inotrope requirement for hypothesized risk factors. Patients were followed for a mean 5.3 years to determine longitudinal mortality. The incidence of PGD was 16.5%. No significant differences were found with respect to age, sex, race, body mass index, predicted heart mass mismatch, pretransplant amiodarone therapy, or pretransplant mechanical circulatory support (MCS) between recipients with PGD versus no PGD. Each 10 minute increase in ischemic time was associated with 5% greater odds of PGD (OR = 1.05 [95% CI, 1.00-1.10]; p = 0.049). Pretransplant MCS, predicted heart mass mismatch ≥30%, and pretransplant amiodarone therapy were associated with high-immediate postoperative inotropic requirement. The 30 day, 1 year, and 5 year mortality for patients with PGD were 28.4%, 38.0%, and 45.8%, respectively, compared with 1.9%, 7.1%, and 21.5% for those without PGD (log-rank, p < 0.0001). PGD heralded high 30 day, 1 year, and 5 year mortality. Pretransplant MCS, predicted heart mass mismatch, and amiodarone exposure were associated with high-inotrope requirement, while prolonged ischemic time and multiple perioperative transfusions were associated with consensus-defined PGD, which may have important clinical implications under the revised United Network for Organ Sharing allocation system. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|